TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 4 | -2 | -5 | 108 | 14 | 257 | 956 | 222 |
P | %wins | 25 | 25 | 75 | 75 | 75 | 100 | 63 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/17/08 13:44 | 8/26/08 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Anderson Stephen Charles | A1 | O | CFO,Secr | P.a | 68 | 6.77 | 0 | 10 | 71 | 24 | I | -98 | -69 | -60 | -52 | -25 | -20 | -8 | -13 | 6 | 0 | 133 | 44 | 455 | 999 |
11/14/08 12:18 | 11/12/08 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Anderson Stephen Charles | A1 | O | CFO,Secr | P.am | 7 | 2.43 | 0 | 3 | 30 | 13 | I | -98 | -69 | -59 | -46 | -33 | -12 | -4 | -6 | -2 | -2 | 147 | 18 | 385 | 999 |
11/13/08 18:53 | 11/12/08 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Anderson Stephen Charles | A1 | O | CFO,Secr | P.m | 7 | 2.43 | 0 | 3 | 2 | I | -98 | -67 | -58 | -49 | -34 | -15 | -6 | -13 | -2 | -2 | 190 | 60 | 230 | 999 | |
8/27/08 19:14 | 8/26/08 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Anderson Stephen Charles | A1 | O | CFO,Secr | P | 68 | 6.77 | 0 | 10 | New | 10 | I | -92 | -90 | -25 | 32 | 42 | 48 | 48 | 38 | -8 | -14 | -37 | -65 | -43 | 399 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |